The investment round was led by Angels in MedCity and Angel Academe.
"We are really excited to be starting the next phase of BeamLine and initiating our first in-clinic trials. Being part of Angels in Medcity and Angel Academe has offered us such diverse but relevant experience that has and will greatly accelerate our growth."
The funding round includes participation from the LBA EIS Roundtable Syndicate Fund 2016 to support market growth.
"We have made significant progress over the past year and, thanks to the support of Angel networks, are well-positioned to grow as the use of novel materials in medical devices increases."
The funding will support production lab setup and initial European sales.
"Bringing these technologies together will allow us to provide rapid access to accurate blood testing outside hospital which could transform the delivery of healthcare."